NCT03570021 2026-03-06
ESTIMABL3
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Active not recruiting
Clinical Trials
22 trialsNCT06554652 2026-02-27
Selective Neck Dissection Versus Modified Neck Dissection in PTC
Fudan University
Phase 3 Recruiting
NCT06558981 2026-02-27
Adjuvant Radiotherapy in High Risk Locally Advanced DTC
Fudan University
Phase 3 Recruiting
NCT06860971 2025-12-31
A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3 Recruiting
NCT05999630 2025-10-28
Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer
Vanderbilt University Medical Center
Phase 3 Recruiting
NCT04290663 2025-10-14
INTERMEDIATE
Centre Francois Baclesse
Phase 3 Recruiting
NCT03690388 2025-09-25
A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy
Exelixis
Phase 3 Active not recruiting
NCT00410761 2025-09-24
An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer
Sanofi
Phase 3 Completed
NCT06082180 2023-10-13
A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3 Recruiting
NCT01321554 2023-06-22
SELECT
Eisai Inc.
Phase 3 Completed
NCT05468554 2022-10-19
METHYR
Medical University of Bialystok
Phase 3 Not yet recruiting
NCT00704730 2021-04-20
EXAM
Exelixis
Phase 3 Completed
NCT00984282 2018-09-13
Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer
Bayer
Phase 3 Completed
NCT00115895 2018-03-02
The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy
University of Helsinki
Phase 3 Unknown
NCT02112370 2017-08-04
REBT
Seoul National University Hospital
Phase 3 Completed
NCT00795782 2016-04-15
Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma
Samsung Medical Center
Phase 3 Completed
NCT00196729 2015-03-18
Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration
Sanofi
Phase 3 Completed
NCT01551914 2014-07-01
FOThyr
Nantes University Hospital
Phase 3 Unknown
NCT01701349 2014-05-01
FACT2
Mateon Therapeutics
Phase 3 Withdrawn
NCT01126060 2011-12-19
Efficacy of Fibrin Sealant to Reduce the Amount of Post-thyroidectomy Drain
Samsung Medical Center
Phase 3 Completed
NCT00794053 2009-07-15
The Usefulness of Staining Lymph Nodes During Operations for Cancer Thyroid in Detecting the Nodes That Have Cancer
University of Alexandria
Phase 3 Completed
NCT00435851 2007-02-19
Estimabl
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Unknown